N-Benzyloxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide
- $45 - $377
- Product name: N-Benzyloxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide
- CAS: 2096330-26-4
- MF: C20H24BNO4
- MW: 353.22
- EINECS:941-006-1
- MDL Number:MFCD18827484
- Synonyms:N-Benzyloxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide;Benzamide, N-(phenylmethoxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;4-(Benzyloxycarbamoyl)benzeneboronic acid pinacol ester, 95%,
9 prices
Selected condition:
Brand
- AK Scientific
- Crysdot
- Matrix Scientific
- SynQuest Laboratories
- TRC
Package
- 250mg
- 500mg
- 1g
- 2.5g
- 5g
- 10g
- ManufacturerAK Scientific
- Product number6085DU
- Product descriptionN-Benzyloxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide
- Packaging5g
- Price$251
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12189358
- Product descriptionN-(Benzyloxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide 97%
- Packaging10g
- Price$377
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number102230
- Product descriptionN-Benzyloxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide >95%
- Packaging5g
- Price$281
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number102230
- Product descriptionN-Benzyloxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide >95%
- Packaging1g
- Price$71
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number102230
- Product descriptionN-Benzyloxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide >95%
- Packaging500mg
- Price$53
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number8H60-1-AS
- Product descriptionN-Benzyloxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide
- Packaging1g
- Price$104
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number8H60-1-AS
- Product descriptionN-Benzyloxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide
- Packaging5G
- Price$212
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB316148
- Product descriptionN-Benzyloxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzamide
- Packaging250mg
- Price$45
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB316148
- Product descriptionN-Benzyloxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzamide
- Packaging2.5g
- Price$175
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 6085DU | N-Benzyloxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide | 5g | $251 | 2021-12-16 | Buy |
Crysdot | CD12189358 | N-(Benzyloxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide 97% | 10g | $377 | 2021-12-16 | Buy |
Matrix Scientific | 102230 | N-Benzyloxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide >95% | 5g | $281 | 2021-12-16 | Buy |
Matrix Scientific | 102230 | N-Benzyloxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide >95% | 1g | $71 | 2021-12-16 | Buy |
Matrix Scientific | 102230 | N-Benzyloxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide >95% | 500mg | $53 | 2021-12-16 | Buy |
SynQuest Laboratories | 8H60-1-AS | N-Benzyloxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide | 1g | $104 | 2021-12-16 | Buy |
SynQuest Laboratories | 8H60-1-AS | N-Benzyloxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide | 5G | $212 | 2021-12-16 | Buy |
TRC | B316148 | N-Benzyloxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzamide | 250mg | $45 | 2021-12-16 | Buy |
TRC | B316148 | N-Benzyloxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzamide | 2.5g | $175 | 2021-12-16 | Buy |
Properties
Density :1.14±0.1 g/cm3(Predicted)
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|